The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Determinants of response to checkpoint inhibition in ovarian cancer.
 
Andrea Leigh Buras
No Relationships to Disclose
 
Alexandra Martin
No Relationships to Disclose
 
Jun Min Zhou
No Relationships to Disclose
 
David C Boulware
No Relationships to Disclose
 
Jose Conejo-Garcia
Stock and Other Ownership Interests - Allogene Therapeutics; Anixa Biosciences; Compass Therapeutics
Honoraria - Anixa Biosciences; Compass Therapeutics; Leidos
Consulting or Advisory Role - Anixa Biosciences; Compass Therapeutics; Leidos
Research Funding - Anixa Biosciences; Compass Therapeutics
Patents, Royalties, Other Intellectual Property - Anixa Biosciences; Compass Therapeutics
Travel, Accommodations, Expenses - Compass Therapeutics; Leidos
 
Robert Michael Wenham
Stock and Other Ownership Interests - Ovation Diagnostics
Honoraria - Tesaro
Consulting or Advisory Role - Abbvie; AstraZeneca; Clovis Oncology; Genentech; GlaxoSmithKline; Legend Biotech; Merck; Mersana; Regeneron; Seattle Genetics/Astellas; Tesaro
Speakers' Bureau - Clovis Oncology; Genentech; Tesaro
Research Funding - Anixa Biosciences (Inst); Merck (Inst); Prescient Therapeutics (Inst)
Travel, Accommodations, Expenses - TapImmune Inc.
Other Relationship - AstraZeneca; GlaxoSmithKline/Tesaro